| 股票 | 申万二级 | PE | 前瞻PE | PEG | PB | 股息率 | 分红率 | 毛利率 | 固定资产 | 债/EBITDA | FCF/市值 | 营收3年 | 去年 | YTD | 近一年 | 回撤 | 波动 | 市值亿 ▾ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 华东医药 000963 | 化学制药 | 13.9 | 12.8 | 1.60 | 1.89 | 3.4% | 46% | 32% | 13% | 0.4 | 5.8% | +5% | +18% | -30% | -40% | -41% | 32% | 480 |
| 丽珠集团 000513 | 化学制药 | 14.2 | 11.5 | 0.96 | 1.78 | 5.3% | 63% | 65% | 19% | 1.2 | 11.9% | -2% | -7% | -19% | -33% | -37% | 24% | 238 |
| 华邦健康 002004 | 化学制药 | 13.7 | — | — | 0.87 | 10.1% | 134% | 38% | 30% | 2.9 | 18.2% | -4% | +11% | -2% | -1% | -30% | 31% | 88 |
| 仙琚制药 002332 | 化学制药 | 22.2 | 18.1 | 1.21 | 1.44 | 3.5% | 67% | 58% | 39% | 0.2 | 5.3% | -5% | -6% | -2% | -22% | -28% | 20% | 86 |
| 力生制药 002393 | 化学制药 | 28.4 | — | — | 0.96 | 5.4% | 49% | 58% | 18% | 0.1 | 2.3% | +7% | +27% | -19% | -31% | -32% | 29% | 43 |
| 小方制药 603207 | 化学制药 | 21.2 | — | — | 3.57 | 4.2% | 90% | 65% | 27% | 0.0 | 2.0% | +5% | +11% | -11% | -27% | -39% | 32% | 41 |
| 司太立 603520 | 化学制药 | 183.1 | 29.6 | 0.37 | 1.55 | 3.4% | 1500% | 24% | 49% | 7.6 | -5.6% | +5% | +10% | -4% | -23% | -41% | 43% | 38 |
| 星昊医药 920017 | 化学制药 | 17.7 | — | — | 1.25 | 3.6% | 54% | 74% | 40% | 0.1 | 4.5% | +2% | +33% | -6% | — | — | — | 20 |
点表头排序。市值单位亿元;去年/YTD 为前复权涨幅;债/EBITDA = 有息负债 ÷ EBITDA。